Translating academic drug discovery

Translating academic drug discovery projects to benefit 

The drug discovery and development platform (DDD) platform makes use of fundamental academic research discoveries across the country and validates these as drug discovery targets and creates lead molecules that would provide attractive future investment as opportunities within the private sector.

Over the past years, DDD has successfully developed therapeutic discoveries with numerous academic groups across the country. Several projects have been out-licensing to industry or established as new spin-off companies. The combination of tools available at SciLifeLab units provide excellent opportunities for drug discovery and development, at different points in the route to new treatments.

With its mission to support researchers in developing prototypes for new drugs, the DDD platform is focused on providing state-of-the-art drug discovery technologies to scientists across the country.


Last updated: 2024-04-15

Content Responsible: Josefin Lundgren Gawell(